Lv41
530 积分 2023-07-19 加入
The expanding universe of PARP1-mediated molecular and therapeutic mechanisms
3个月前
已完结
Photocontrolled trimethoprim PROTACs targeting the eDHFR protein tag
3个月前
已完结
An extending ATR–CHK1 circuitry: the replication stress response and beyond
4个月前
已完结
The Landscape of Alterations in DNA Damage Response Pathways in Colorectal Cancer
4个月前
已完结
Pharmacological Modulation of the Crosstalk between Aberrant Janus Kinase Signaling and Epigenetic Modifiers of the Histone Deacetylase Family to Treat Cancer
4个月前
已完结
A Comprehensive Review on Human Metapneumovirus
6个月前
已关闭
A STAT inhibitor patent review: progress since 2011
9个月前
已完结
Abstract DDT02-01: RBN-2397: A first-in-class PARP7 inhibitor targeting a newly discovered cancer vulnerability in stress-signaling pathways
10个月前
已关闭
皖公网安备34019202002308
